drugset / Trial / NCT00481104
Evaluation of Long Term Safety of Tesofensine in Patients With Obesity
NaSingle-groupOpen-labelTreatment
Summary
Purpose of the study is to evaluate the long term safety of tesofensine in obese patients
Timeline
- Start
- 2007-05
- Primary completion
- 2008-09
- Completion
- 2008-11
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Tesofensine | Small molecule | 0.25 mg | — |
| Subject | Tesofensine | Small molecule | 0.5 mg | — |
| Subject | Tesofensine | Small molecule | 1 mg | — |